Concurrent Investment Advisors LLC Buys 10,022 Shares of Marsh & McLennan Companies, Inc. $MRSH

Concurrent Investment Advisors LLC boosted its stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 70.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,202 shares of the financial services provider’s stock after purchasing an additional 10,022 shares during the period. Concurrent Investment Advisors LLC’s holdings in Marsh & McLennan Companies were worth $4,490,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. D.A. Davidson & CO. increased its holdings in shares of Marsh & McLennan Companies by 1.2% during the third quarter. D.A. Davidson & CO. now owns 4,514 shares of the financial services provider’s stock worth $910,000 after buying an additional 54 shares in the last quarter. Procyon Advisors LLC grew its position in Marsh & McLennan Companies by 2.5% during the 4th quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider’s stock worth $423,000 after acquiring an additional 56 shares during the last quarter. PFG Investments LLC increased its holdings in Marsh & McLennan Companies by 3.3% in the 4th quarter. PFG Investments LLC now owns 1,758 shares of the financial services provider’s stock worth $326,000 after purchasing an additional 56 shares in the last quarter. Lindenwold Advisors INC raised its position in Marsh & McLennan Companies by 0.4% in the third quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider’s stock valued at $3,022,000 after purchasing an additional 62 shares during the last quarter. Finally, Ashton Thomas Securities LLC boosted its stake in shares of Marsh & McLennan Companies by 1.8% during the third quarter. Ashton Thomas Securities LLC now owns 3,663 shares of the financial services provider’s stock valued at $736,000 after purchasing an additional 63 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Mizuho lowered their price objective on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Keefe, Bruyette & Woods lifted their target price on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research report on Friday, April 17th. JPMorgan Chase & Co. decreased their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research report on Thursday, April 9th. Barclays dropped their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Finally, Raymond James Financial raised shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective on the stock in a research note on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $205.33.

Marsh & McLennan Companies Price Performance

Shares of MRSH stock opened at $170.31 on Tuesday. The company has a market capitalization of $82.06 billion, a PE ratio of 21.29, a PEG ratio of 2.48 and a beta of 0.75. The firm has a 50 day moving average of $173.87. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a one year low of $164.89 and a one year high of $235.78.

Marsh & McLennan Companies (NYSE:MRSH) last released its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm had revenue of $7.30 billion during the quarter. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts expect that Marsh & McLennan Companies, Inc. will post 10.36 earnings per share for the current year.

Marsh & McLennan Companies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be issued a $0.90 dividend. The ex-dividend date is Thursday, April 9th. This represents a $3.60 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies’s payout ratio is presently 45.00%.

Insider Transactions at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,655 shares of the business’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the transaction, the chief executive officer owned 116,811 shares in the company, valued at $21,411,456.30. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.38% of the stock is currently owned by insiders.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.